Ping Lü
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Molecular Medicine top 5%
Papers in
- Pharmacology 11
- Pharmacogenetics and Drug Metabolism 10
- Drug-Induced Hepatotoxicity and Protection 3
- Oncology 16
- Drug Transport and Resistance Mechanisms 7
- PARP inhibition in cancer therapy 3
- Co-authors
- Dirk Bald (5 shared papers)Anil Koul (3 shared papers)Cristina Villellas (2 shared papers)Christopher M. Anderson (6 shared papers)Toshitaka Nabeshima (7 shared papers)Akihiro Mouri (7 shared papers)Takayoshi Mamiya (7 shared papers)Takashi Ikejima (5 shared papers)
- Journals
- Drug Metabolism and Disposition (6 papers)Behavioural Brain Research (3 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Xenobiotica (2 papers)Archives of Biochemistry and Biophysics (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Ping Lü
66 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 122
- Pharmacology 272
- Molecular Medicine 132
- Infectious Diseases 473
- Biological Psychiatry 58
- Pharmacology 297
Countries citing papers authored by Ping Lü
This map shows the geographic impact of Ping Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Lü more than expected).
Fields of papers citing papers by Ping Lü
This network shows the impact of papers produced by Ping Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Lü. The network helps show where Ping Lü may publish in the future.
Co-authors
The 25 scholars most cited alongside Ping Lü, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 227 | |
| 2 | 2017 | 190 | |
| 3 | 2009 | 186 | |
| 4 | 2011 | 149 | |
| 5 | 2003 | 128 | |
| 6 | 2004 | 103 | |
| 7 | 1994 | 97 | |
| 8 | 2003 | 89 | |
| 9 | 2012 | 86 | |
| 10 | 2009 | 86 | |
| 11 | 2018 | 76 | |
| 12 | 2007 | 74 | |
| 13 | 2009 | 72 | |
| 14 | 2021 | 69 | |
| 15 | 2019 | 66 | |
| 16 | 2013 | 60 | |
| 17 | 2017 | 60 | |
| 18 | 2014 | 57 | |
| 19 | 1992 | 55 | |
| 20 | 2011 | 52 |
About Ping Lü
Ping Lü is a scholar working on Pharmacology, Oncology, Infectious Diseases, Cellular and Molecular Neuroscience and Molecular Biology, having authored 70 papers that have together received 2.8k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (7 papers), Neuroscience and Neuropharmacology Research (6 papers), Tuberculosis Research and Epidemiology (5 papers), Mycobacterium research and diagnosis (4 papers), PARP inhibition in cancer therapy (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Pharmacology (272 citations), Molecular Medicine (132 citations), Infectious Diseases (473 citations), Biological Psychiatry (58 citations) and Pharmacology (297 citations). Ping Lü has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Dirk Bald, Anil Koul, Cristina Villellas, Christopher M. Anderson, Toshitaka Nabeshima, Akihiro Mouri, Takayoshi Mamiya, Takashi Ikejima, Taku Nagai and Lingling Lu. Their work appears in journals such as Drug Metabolism and Disposition, Behavioural Brain Research, Journal of Pharmacology and Experimental Therapeutics, Xenobiotica and Archives of Biochemistry and Biophysics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.